Institutional investors purchased a net $14.8 million shares of AZN during the quarter ended September 2014 and now own 7.05% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
KCG AMERICAS LLC Bought 2.5 Million shares of AstraZeneca
ARROWSTREET CAPITAL LP Bought 1.2 Million shares of AstraZeneca
CITIGROUP GLOBAL MARKETS INC. (B... Bought 740.6 Thousand shares of AstraZeneca